Note: This page contains side effects data for the generic drug lisdexamfetamine. mon side effects of Vyvanse include: insomnia and irritability. Other side effects include: dizziness, weight loss, and xerostomia. See below for a comprehensive list of adverse effects.Applies to lisdexamfetamine: oral capsule As well as its needed effects, lisdexamfetamine (the active ingredient contained in Vyvanse) may cause unwanted side effects that require medical attention. If any of the following side effects occur while taking lisdexamfetamine, check with your doctor immediately: If any of the following symptoms of overdose occur while taking lisdexamfetamine, get emergency help immediately: Some lisdexamfetamine side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:

Applies to lisdexamfetamine: oral capsuleAll side effects listed, unless otherwise noted, were reported in pediatric patients.Black Lab Puppies OmahaOther side effects have included decreased appetite (39%), headache, and pyrexia (2%).Mazda Cx 9 Tire ChainsGastrointestinal side effects have included upper abdominal pain (12%), dry mouth (5%), nausea (6%), and vomiting (9%). Husky Puppies For Sale DorsetGastrointestinal side effects associated with amphetamine or lisdexamfetamine (the active ingredient contained in Vyvanse) have included dryness of mouth, unpleasant taste, diarrhea, and constipation.Metabolic side effects have included weight loss.Nervous system side effects have included insomnia (19%), dizziness (5%), initial insomnia (4%), and somnolence (2%).

Nervous system side effects associated with the use of recommended doses of amphetamine or lisdexamfetamine (the active ingredient contained in Vyvanse) have included dyskinesia and seizures. Postmarketing reports have included psychotic episodes, mania, hallucination, and aggression.Psychiatric side effects have included irritability (10%), affect lability (3%), and tic (2%). Psychiatric side effects associated with the use of recommended doses of amphetamine or lisdexamfetamine (the active ingredient contained in Vyvanse) have included overstimulation, restlessness, euphoria, dysphoria, depression, tremor, and exacerbation of motor and phonic tics and Tourette syndrome. Postmarketing reports have included dermatillomania.Dermatological side effects have included rash (3%). Dermatological side effects associated with amphetamine or lisdexamfetamine (the active ingredient contained in Vyvanse) have included serious skin rashes, Stevens Johnson Syndrome, and toxic epidermal necrolysis.Cardiovascular side effects associated with amphetamine or lisdexamfetamine (the active ingredient contained in Vyvanse) have included palpitations, tachycardia, increased blood pressure, sudden death, stroke, and myocardial infarction.

Cardiomyopathy has been associated with chronic amphetamine use.Hypersensitivity reactions associated with amphetamine or lisdexamfetamine (the active ingredient contained in Vyvanse) have included urticaria, angioedema, anaphylaxis, Stevens Johnson Syndrome, and toxic epidermal necrolysis.Genitourinary side effects associated with amphetamine or lisdexamfetamine (the active ingredient contained in Vyvanse) have included decreased libido (less than 2%), erectile dysfunction (less than 2%), impotence, and changes in libido. Postmarketing side effects include frequent or prolonged erections.Ocular side effects including blurred vision have been reported.Shire US Inc, Florence, KY. It is possible that some side effects of Vyvanse may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice. Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect.

In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist. How government subsidies, taxes and restaurants affect our weight

Over the holiday weekend, many Americans enjoyed the tastes of freedom: hot dogs and hamburgers fresh off the grill; corn dripping with melted butter; potatoes flash-fried in oil, smothered in mayonnaise, covered with salt. At parades, parks and backyard barbecues everywhere, the high-fructose corn syrup flowed freely.Alas, as we are so often reminded, freedom isn’t free. And, as a bumper crop of research reminded us on Tuesday, neither are our dietary choices.American diets are shaped by federal agricultural subsidies that assure cheap and easy access to the highest-calorie foods. Restaurants add salt and saturated fats to lure us away from our...FRIDAY, June 12, 2015 (HealthDay News) -- A drug marketed for attention deficit hyperactivity disorder might improve memory and concentration problems associated with menopause, a new, small study suggests.Vyvanse (lisdexamfetamine), a stimulant, is usually prescribed to children and adults with ADHD. But researchers found it also may help to improve menopausal women's "executive function" -- brain activities such as memory, reasoning, multitasking, planning and problem-solving."

We always hear about hot flashes, irregular periods and insomnia classically linked to menopause, but there are other symptoms equally annoying but less talked about," said Dr. Sheryl Ross, an obstetrician-gynecologist at Providence Saint John's Health Center in Santa Monica, Calif., who was not involved in the study. "Cognitive changes happen in the majority of women going through menopause, and memory loss, poor concentration, a short attention span and other cognitive changes can be disruptive and frustrating."The study was funded by Shire, the drug's maker, and the U.S. National Institutes of Health. The findings were published online June 11 in the journal Psychopharmacology.The study authors randomly gave 32 women 40 to 60 milligrams of Vyvanse or a placebo daily for four weeks. All were between ages 45 and 60, were either going through or just finishing menopause, and had complained of difficulties with executive function.None had a history of ADHD, but all scored high enough on an assessment of symptoms to show they were experiencing executive function difficulties at the time of the study.

They also underwent several tests related to memory and attention.After four weeks, the women had a two-week break before the groups switched. Women who got a placebo the first time now received the real medication and vice versa for another four weeks.The researchers found that the women had better scores on their symptoms assessments while taking the medication. They also scored better on one of the three memory and concentration tests while taking Vyvanse.Another women's-health expert stressed the need for more studies and more treatment options for menopausal women."We need more research before changing our clinical practice, but it is encouraging that we are looking at other treatments for a variety of cognitive, mood and physical symptoms that are present during perimenopause and menopause for women," said Dr. Nicole Cirino, director of women's mental health and wellness at Oregon Health & Science University. "It's especially exciting to see this research for women who cannot tolerate hormone replacement therapy," added Cirino, who was not involved in the study.

Many women use hormone replacement therapy for menopausal symptoms, but how much it can help mental functioning is controversial, said Dr. Kevin Ault, an obstetrician-gynecologist and professor at the University of Kansas Medical Center. The evidence has not clearly shown that it does or does not help.Not every woman is comfortable taking hormone replacement therapy or cannot take it due to other medical complications, Ross noted. "Even though this is a small study, it shows that other medications can be safe and effective in treating annoying cognitive side effects of menopause," she said. While the women in the study were taking the medication, their blood pressure and heart rate increased but stayed in the normal range overall. The study authors did not report other major side effects. "One of the problems with having a small study like this is that you're not going to see the big picture with side effects," Ault said. Known side effects of Vyvanse include trouble sleeping, nervousness, dizziness, skin numbness, irregular heartbeat, headaches, nausea, vomiting, weight loss and loss of appetite, said Ross.There are also individuals who should not take Vyvanse based on their health history, Cirino said, such as those with a history of heart conditions or a history of addiction or dependence."